Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
Teva to cut up to 1,700 jobs in streamlining plan — report | The Times of Israel
The Possible Reason why Teva (NYSE:TEVA) is Still Trading Below Intrinsic Value - Simply Wall St News
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
DEF 14A
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Reports Third Quarter 2021 Financial Results
Teva Pharmaceutical Industries (NYSE:TEVA) Has No Shortage Of Debt | Nasdaq
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Teva Pharm Q3 profit misses estimates, sees recovery into Q4 | Reuters
TEVA 2022 Earnings Date, Forecast & Call Transcript (Teva Pharmaceutical Industries)
What Kind Of Investor Owns Most Of Teva Pharmaceutical Industries Limited (NYSE:TEVA)?
Teva Reports First Quarter 2022 Financial Results
Teva Reports Second Quarter 2021 Financial Results | Business Wire
Teva Pharmaceutical Industries Limited - AnnualReports.com
Form 6-K
Teva Pharmaceutical Industries Limited Financial Statements – NYSE:TEVA – TradingView
Teva gets a boost as billionaire Buffett reports $358M stake | Fierce Pharma
Teva climbs on report it is mulling 10,000 job cuts | Financial Times
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Pharmaceuticals on Twitter: "Yesterday we shared Teva's business results for Q4 and full year 2021. Learn more here: https://t.co/ZWekP2kzJy #QuarterlyResults #Earnings $Teva Forward-looking statements are subject to the cautionary note included
DEF 14A
